C Stauch, H Reiber, M Rauchenzauner… - Multiple Sclerosis …, 2011 - msj.sagepub.com ... Advertisement. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis. ... Sensitive detection of intrathecal IgM synthesis. Intrathecal IgM synthesis ... Cited by 1 - Related articles - All 4 versions
MD Baker, YC Chen, SU Shah… - Molecular and cellular …, 2011 - ncbi.nlm.nih.gov K(V)1.1 is a Shaker homologue K(+) channel that contributes to the juxta-paranodal membrane conductance in myelinated axons, and is blocked by fampridine (4-aminopyridine), used to treat the symptoms of multiple sclerosis. The present experiments investigate K(V)1.1 function ...
A Grahn, M Studahl, S Nilsson… - Clinical and Vaccine …, 2011 - Am Soc Microbiol Page 1. 1 Varicella-zoster virus (VZV) glycoprotein E: a serological antigen for detection 1 of intrathecal antibodies to VZV in central nervous system infections, without 2 ... of intrathecal antibodies to VZV in central nervous system infections, without 48 ... All 2 versions
T Rekand… - … medicine: official journal of the UEMS …, 2011 - ncbi.nlm.nih.gov BACKGROUND: Spasticity is a frequent disabling symptom in patients with multiple sclerosis, which contributes to functional deterioration. OBJECTIVE: To evaluate the long-term effect of intrathecal baclofen therapy in multiple sclerosis-related spasticity and to ... All 2 versions
TR Deer - Atlas of Implantable Therapies for Pain Management, 2011 - Springer Intrathecal infusions of analgesics have been utilized increasingly since the late 1980s for the treatment of persistent pain. Early credit goes to Leonard Corning, who administered neuraxial local anesthetic in 1885. Corning's work led to an interest in using this method to treat ... Related articles